CancerCure of America - Care, Understand, Research & End – Trademark Portfolio
Entity Type: 03
CancerCure of America - Care, Understand, Research & End holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CANCERCURE OF AMERICA CARE, UNDERSTAND,RESEARCH & END. The owner is based in LARKSPUR, CA.
Suite 340
LARKSPUR, CA 94939
Showing of trademarks Trademarks
Trademark Classifications
CancerCure of America - Care, Understand, Research & End's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does CancerCure of America - Care, Understand, Research & End have?
CancerCure of America - Care, Understand, Research & End has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does CancerCure of America - Care, Understand, Research & End file in?
CancerCure of America - Care, Understand, Research & End files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are CancerCure of America - Care, Understand, Research & End's most well-known trademarks?
CancerCure of America - Care, Understand, Research & End's registered trademark portfolio includes well-known marks such as CANCERCURE OF AMERICA CARE, UNDERSTAND,RESEARCH & END. These are among 1 currently registered trademark in the portfolio.
What is CancerCure of America - Care, Understand, Research & End's trademark registration success rate?
CancerCure of America - Care, Understand, Research & End has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.